Maria C. Puertas

Badalona, CT 08916, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

Journal: Research square
Published: June 12, 2026

HIV-1 envelope glycoprotein modulates CXCR4 clustering and dynamics on the T cell membrane.

HIV-1 envelope glycoprotein modulates CXCR4 clustering and dynamics on the T cell membrane.

Journal: eLife
Published: May 12, 2026

Increases in total HIV-1 nucleic acid in whole blood precede plasma RNA rebound during pediatric analytical treatment interruption.

Increases in total HIV-1 nucleic acid in whole blood precede plasma RNA rebound during pediatric analytical treatment interruption.

Journal: AIDS (London, England)
Published: December 13, 2025

Increases in total HIV-1 nucleic acid in whole blood precede plasma rna rebound during paediatric analytical treatment interruption.

Increases in total HIV-1 nucleic acid in whole blood precede plasma rna rebound during paediatric analytical treatment interruption.

Journal: AIDS (London, England)
Published: December 13, 2025

Hope for treatment-free remission in children born with HIV.

Hope for treatment-free remission in children born with HIV.

Journal: The lancet. HIV
Published: July 31, 2025

Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery.

Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery.

Journal: Frontiers in immunology
Published: April 25, 2025

Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.

Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.

Journal: PLoS pathogens
Published: March 03, 2025

Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.

Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.

Journal: Nature medicine
Published: February 05, 2025

Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.

Protein Nanoparticles for Targeted SARS-CoV-2 Trapping and Neutralization.

Journal: Advanced healthcare materials
Published: September 04, 2024

Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.

Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir.

Journal: The Journal of clinical investigation
Published: June 20, 2024

Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood.

Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood.

Journal: The Journal of infectious diseases
Published: May 23, 2024

Viremic non-progression in HIV/SIV infection: A tied game between virus and host.

Viremic non-progression in HIV/SIV infection: A tied game between virus and host.

Journal: Cell reports. Medicine
Published: May 10, 2024
Showing 1-12 of 67

Last Updated: 09/26/2026